Centinel Spine Holdco files for NYSE IPO

By Stephen Nakrosis Medical technology company Centinel Spine Holdco filed for an initial public offering. The company didn't give a size for its IPO, nor did it offer an expected price range. Centinel said it plans to apply for a listing on the New York Stock Exchange under the symbol CNTL. The company said it plans to transform spine surgery by advancing motion-preserving solutions for the cervical and lumbar spine. It added its focus is on Total Disc Replacement, saying it was a fundamentally different and increasingly important approach to spine surgery. For the six months ended June 30, the company reported $10.2 million in net income on $85.2 million in revenue. For the six months ended June 30, 2025, the company had a net loss of $503,000 on a revenue of $60 million. AW Alpha Capital, Oman Investment Authority, and Viscogliosi Brothers are listed among the company's principal stockholders. Write to Stephen Nakrosis at stephen.nakrosis@wsj.com (END) Dow Jones Newswires October 07, 2026 17:11 ET (21:11 GMT) Copyright (c) 2026 Dow Jones & Company, Inc. The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.